28.01.2023 Views

CENSIS white paper: Intellectual Property in Business

2023: This CENSIS white paper sets out to make the topic of IP more approachable, less intimidating and more manageable, offering experience-based advice and methods are are designed to help businesses structure their IP- related issues and makes the best of their IP. Covering: The role of IP, IP management during growth, IP strategy for expanding companies and corporates, Business IP Canvas - merging IP with your business model.

2023: This CENSIS white paper sets out to make the topic of IP more approachable, less intimidating and more manageable, offering experience-based advice and methods are are designed to help businesses structure their IP- related issues and makes the best of their IP.
Covering:
The role of IP, IP management during growth, IP strategy for expanding companies and corporates, Business IP Canvas - merging IP with your business model.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Intellectual</strong> <strong>Property</strong> <strong>in</strong> Bus<strong>in</strong>ess: IP basics, IP management, IP strategy<br />

IP Management dur<strong>in</strong>g Growth (cont<strong>in</strong>ued)<br />

The open-source software example shows that there<br />

are sometimes strong reasons to let others use your<br />

<strong>in</strong>tellectual property with fewer restrictions than the law<br />

establishes on your behalf automatically. 46<br />

Another great example of the open access model, from<br />

a less technical field, is the Creative Commons <strong>in</strong>itiative<br />

which facilitated access to many creative works under<br />

‘some rights reserved’, such as giv<strong>in</strong>g the author credit,<br />

attribution or a share. 47<br />

The m<strong>in</strong>dset beh<strong>in</strong>d ‘open access’ spilled over <strong>in</strong>to the<br />

patent world, result<strong>in</strong>g <strong>in</strong> ‘patentleft’ models – <strong>in</strong> an<br />

analogy to copyleft – where the patent owner releases<br />

its patents to the public <strong>in</strong> the spirit of the open-source<br />

movement, with the assumption that any follow-on<br />

solutions will be released under the same ‘open terms’.<br />

In 2014, Tesla shocked the public by mak<strong>in</strong>g its patents<br />

available to everyone <strong>in</strong>terested <strong>in</strong> us<strong>in</strong>g its technology<br />

<strong>in</strong> good faith. This patent pledge had one condition,<br />

namely that the <strong>in</strong>terested party did not assert any IP<br />

rights aga<strong>in</strong>st Tesla or any other party and did not copy<br />

Tesla’s designs. The outcome: Tesla ga<strong>in</strong>ed access<br />

to various improvements <strong>in</strong> technologies relat<strong>in</strong>g to<br />

electric vehicles. The move also helped Tesla to grow<br />

the EV customer base more quickly than it could<br />

have done by work<strong>in</strong>g alone <strong>in</strong> what was at the time a<br />

nascent market.<br />

A similar move was taken by GlaxoSmithKl<strong>in</strong>e (GSK)<br />

when it opened its patent pool of 800 granted and<br />

pend<strong>in</strong>g patents to boost development of new<br />

formulations aga<strong>in</strong>st neglected tropical diseases <strong>in</strong><br />

least-developed and low-<strong>in</strong>come countries. GSK<br />

expanded its pledge to not file for patent protection <strong>in</strong><br />

these regions. 48<br />

Co-creation 49 and co-design models also assume ‘open<br />

access’ to the knowledge and <strong>in</strong>novation of a company<br />

and the <strong>in</strong>volvement of ‘outsiders’ <strong>in</strong> the ideation<br />

process. Very often these outsiders are the source<br />

of new ideas and new IP. That fresh perspective <strong>in</strong><br />

design<strong>in</strong>g processes and bus<strong>in</strong>ess ideation is extremely<br />

valuable for companies that generously use this source<br />

of <strong>in</strong>novation as part of an ‘open <strong>in</strong>novation’ approach.<br />

Take-home message: The entrepreneurial journey<br />

assumes a great deal of experimentation <strong>in</strong> terms of<br />

bus<strong>in</strong>ess models, collaborations and IP strategy. The<br />

same applies to experimentation with open-access<br />

bus<strong>in</strong>ess models. After Palfrey, there might be great<br />

value <strong>in</strong> ‘open’ exploitation of your IP portfolio and<br />

lett<strong>in</strong>g others access your company know-how. For<br />

start-ups, it might be less appeal<strong>in</strong>g to open their<br />

patent portfolio where so much resource has been<br />

<strong>in</strong>vested <strong>in</strong> patent registration. But as open-source<br />

software success stories teach us, such collaborative,<br />

shared-benefit approaches are more common among<br />

software developers who take solutions <strong>in</strong>to the<br />

bus<strong>in</strong>esses they are part of.<br />

46<br />

Palfrey (n 5) 107.<br />

47<br />

Ibid 107.<br />

48<br />

‘GSK expands graduated approach to patents and <strong>in</strong>tellectual property to widen access to medic<strong>in</strong>es <strong>in</strong> the world’s poorest countries’ (GSK, 31 March 2016)<br />

<br />

accessed 2 December 2022.<br />

49<br />

C.K. Prahalad and Venkatram Ramaswamy, ‘Co-opt<strong>in</strong>g Customer Competence’ (Harvard Bus<strong>in</strong>ess Review, From the Magaz<strong>in</strong>e (January–February 2000)<br />

accessed 2 December 2022.<br />

32

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!